Search in:

Advanced search

Drugs: Education, Prevention and Policy Volume 27, 2020 - Issue 1

Submit an article Journal homepage

222

Views

CrossRef citations to date

Altmetric

Commentary

‘C’ the potential: needle and syringe programs as hepatitis C treatment sites

Kathleen MillerFaculty of Health Sciences, McMaster University, Hamilton, Canada; Correspondence[email protected]

http://orcid.org/0000-0002-5660-9339

Felicity SheavesNepean Blue Mountains Local Health District, Penrith, Australia;

Louise MaherNepean Blue Mountains Local Health District, Penrith, Australia;

Julie PageNepean Blue Mountains Local Health District, Penrith, Australia;

Ian Bridges-WebbNepean Blue Mountains Local Health District, Penrith, Australia;

Carla TreloarCentre for Social Research in Health, UNSW Sydney

Pages 92-94 | Received 21 Aug 2018, Accepted 11 Feb 2019, Published online: 14 Mar 2019

Cite this article
https://doi.org/10.1080/09687637.2019.1583170
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

References

Broadhead, R.S., Heckathorn, D., Altice, F.V., Hulst, Y., Carbone, M., Friedland, G., … Selwyn, P.A. (2002). Increasing drug users' adherence to HIV treatment: Results of a peer-driven intervention feasibility study. Social Science & Medicine, 55, 235–246. doi:10.1016/S0277-9536(01)00167-8
PubMed Web of Science ®Google Scholar
Bruggmann, P., & Litwin, A.H. (2013). Models of care for the management of hepatitis C virus among people who inject drugs: One size does not fit all. Clinical Infectious Diseases, 57, S56–S61. doi:10.1093/cid/cit271
PubMed Web of Science ®Google Scholar
Eckhardt, B.J., Scherer, M., Winkelstein, E., Marks, K., & Edlin, B.R. (2018). Hepatitis C treatment outcomes for people who inject drugs treated in an accessible care program located at a syringe service program. Open Forum Infectious Diseases, 5, 1–4. doi:10.1093/ofid/ofy048
Web of Science ®Google Scholar
Grebely, J., Dore, G.J., Morin, S., Rockstroh, J.K., & Klein, M.B. (2017). Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there? Journal of the International AIDS Society, 20, 22146. doi:10.7448/IAS.20.1.22146
PubMed Web of Science ®Google Scholar
Kirby Institute. (2017). Monitoring hepatitis C treatment uptake in Australia. Retrieved from https://kirby.unsw.edu.au/sites/default/files/kirby/report/Monitoring-hep-C-treatment-uptake-in-Australia_Iss6-FEB17.pdf
Google Scholar
Kirby Institute. (2018). Australian NSP Survey National Data Report 2013–2017. Retrieved from https://kirby.unsw.edu.au/sites/default/files/kirby/report/ANSPS_National-Data-Report-2013-2017.pdf
Google Scholar
Mason, K., Dodd, Z., Guyton, M., Tookey, P., Lettner, B., Matelski, J., … Powis, J. (2017). Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada. International Journal of Drug Policy, 47, 202–208. doi:10.1016/j.drugpo.2017.05.025
PubMed Web of Science ®Google Scholar
Treloar, C., Rance, J., Yates, K., & Mao, L. (2016). Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs. International Journal of Drug Policy, 27, 138–145. doi:10.1016/j.drugpo.2015.08.018
PubMed Web of Science ®Google Scholar
World Health Organization. (2016). Global heath strategy on viral hepatitis 2016–2021 towards ending viral hepatitis. Retrieved from http://apps.who.int/iris/bitstream/10665/246177/1/WHO-HIV-2016.06
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

‘C’ the potential: needle and syringe programs as hepatitis C treatment sites

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

‘C’ the potential: needle and syringe programs as hepatitis C treatment sites

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date